Effect and Safety of Acupuncture for Type 2 Diabetes Mellitus:A Systematic Review and Meta-analysis of 21 Randomised Controlled Trials

被引:0
|
作者
LI Shu-qing [1 ]
CHEN Jian-rong [2 ]
LIU Mei-lu [3 ]
WANG Yan-ping [1 ]
ZHOU Xu [1 ]
SUN Xin [1 ,4 ]
机构
[1] Evidence-Based Medicine Research Centre, Jiangxi University of Traditional Chinese Medicine
[2] Department of Endocrinology, the First Affiliated Hospital of Nanchang University
[3] Department of Integrated Chinese and Western Medicine,West China Hospital, Sichuan University
[4] Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University
关键词
D O I
暂无
中图分类号
R246.1 [内科];
学科分类号
摘要
Objective: To evaluate the effects of acupuncture on hypoglycaemic outcomes in type 2 diabetes mellitus(T2 DM). Methods: Pub Med, Embase, Cochrane Library, and Clinical Trials.gov were searched from inception up to July 2020, to identify randomised controlled trials(RCTs) that enrolled patients with T2 DM and compared acupuncture combined with antidiabetic drugs to antidiabetic drugs alone. The primary outcomes were haemoglobin A1 c(Hb A1 c) and fasting blood glucose(FBG). The secondary outcomes included 2-h blood glucose(2 h BG), fasting insulin(FINS), homeostatic model assessment for insulin resistance(HOMA-IR), and acupuncture-related adverse events. Mean difference(MD) and 95% confidence interval(CI) were used as the effect measure in the meta-analysis. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation tool. Results: Twenty-one RCTs(n=1,188) were included. The meta-analytic results showed that the acupuncture group had greater reductions in FBG(MD –6.46 mg/d L, 95% CI –11.95 to –0.98; moderate-quality evidence) and HOMA-IR(MD –1.23, 95% CI –2.16 to –0.31; low-quality evidence), but comparable changes in Hb A1 c(MD –0.39%, 95% CI –0.84 to 1.61; very-low-quality evidence), 2 h BG(MD –4.99 mg/d L, 95% CI –20.74 to 10.76; low-quality evidence), and FINS(MD –1.32 μIU/m L, 95% CI –3.76 to 1.12; low-quality evidence). No data on the incidence of diabetic complications were found. All acupuncture-related adverse events reported were mild. Conclusions: The current evidence suggests that acupuncture, as a complementary therapy to antidiabetic drugs, has a small but statistically significant effect on decreasing FBG and improving insulin resistance. The effects of acupuncture on Hb A1 c, 2 h BG, and FINS remain uncertain. Acupuncture is generally safe in patients with mild diabetes. More evidence for the long-term effects of acupuncture on T2 DM is needed.(Registration No. CRD42018115639)
引用
收藏
页码:463 / 471
页数:9
相关论文
共 50 条
  • [1] Effect and Safety of Acupuncture for Type 2 Diabetes Mellitus:A Systematic Review and Meta-analysis of 21 Randomised Controlled Trials
    LI Shuqing
    CHEN Jianrong
    LIU Meilu
    WANG Yanping
    ZHOU Xu
    SUN Xin
    Chinese Journal of Integrative Medicine , 2022, (05) : 463 - 471
  • [2] Effect and Safety of Acupuncture for Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of 21 Randomised Controlled Trials
    Shu-qing Li
    Jian-rong Chen
    Mei-lu Liu
    Yan-ping Wang
    Xu Zhou
    Xin Sun
    Chinese Journal of Integrative Medicine, 2022, 28 : 463 - 471
  • [3] Effect and Safety of Acupuncture for Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of 21 Randomised Controlled Trials
    Li, Shu-qing
    Chen, Jian-rong
    Liu, Mei-lu
    Wang, Yan-ping
    Zhou, Xu
    Sun, Xin
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2022, 28 (05) : 463 - 471
  • [4] Acupuncture for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
    Chen, Chao
    Liu, Jia
    Sun, Mengxiao
    Liu, Weihong
    Han, Juan
    Wang, Hongcai
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2019, 36 : 100 - 112
  • [5] Efficacy and Safety of Acupuncture and Related Techniques for Type 2 Diabetes Mellitus: A Systematic Review of 21 Randomised Controlled Trials
    Zhou, Xu
    Chen, Jianrong
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 116 : 21 - 22
  • [6] Efficacy and Safety of Pioglitazone Monotherapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
    Alam, Fahmida
    Islam, Md Asiful
    Mohamed, Mafauzy
    Ahmad, Imran
    Kamal, Mohammad Amjad
    Donnelly, Richard
    Idris, Iskandar
    Gan, Siew Hua
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Efficacy and Safety of Pioglitazone Monotherapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
    Fahmida Alam
    Md. Asiful Islam
    Mafauzy Mohamed
    Imran Ahmad
    Mohammad Amjad Kamal
    Richard Donnelly
    Iskandar Idris
    Siew Hua Gan
    Scientific Reports, 9
  • [8] Acupuncture in treating obesity combined with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled clinical trials
    Wang, Ying
    Xu, Guang-nan
    Wan, Ren-hong
    Zhou, Xin
    Ma, Li-ying
    Liu, Bing
    Zhang, Yu-yan
    Zhou, Liang
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2022, 49
  • [9] Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Voroneanu, Luminita
    Nistor, Ionut
    Dumea, Raluca
    Apetrii, Mugurel
    Covic, Adrian
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [10] Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Li, Xiaoxuan
    Huang, Xuefei
    Bai, Chongfei
    Qin, Dalian
    Cao, Shousong
    Mei, Qibing
    Ye, Yun
    Wu, Jianming
    FRONTIERS IN PHARMACOLOGY, 2018, 9